Biofrontera AG Profit Margin

Biofrontera AG (BFRA) currently reports a profit margin of -59.75% as of September 2021. That compares with -46.26% in the prior-year period — down 29.2% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Biofrontera AG's profit margin history and peer comparisons.

Biofrontera AG's profit margin decreased from -46.26% to -59.75% — a 29.2% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biofrontera AG's profit margin of -59.75% is lower than the Healthcare sector average of 13.89%. That is roughly 530.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Biofrontera AG's current -59.75% should be judged against Healthcare norms (sector average: 13.89%) and against BFRA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -59.75%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Biofrontera AG, and consider following BFRA for alerts when major investors trade the stock.